Brain

Best Vyvanse Alternative Over the Counter for ADHD – Natural Vyvanse Substitute – Noocube

NooCube NooCube London, May 10, 2025 (GLOBE NEWSWIRE) -- Vyvanse is a prescription medication that is used to treat ADHD…

9 months ago

MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss

A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York,…

9 months ago

Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)

LOS ANGELES, May 10, 2025 (GLOBE NEWSWIRE) -- Losing weight these days can feel more difficult than ever. Despite trying…

9 months ago

6 Best Fat Burners For Women: Top Over the Counter and Online Pills and Fat Burning Supplements For Women Weight Loss In 2025 – Wolfson Brands

Discover the 6 best fat burners for women in 2025. Top OTC & online weight loss pills from Wolfson Brands…

9 months ago

Best Fat Burners For Men 2025: Top Weight Loss Pills & Supplements For Fast Fat Loss – Wolfson Brands Ltd

Discover the best fat burners for men in 2025! Our expert guide ranks the top weight loss pills and supplements…

9 months ago

4 Best Supplements for Muscle Growth in 2025 – Legal Steroid Alternatives & Bodybuilding Supplements for Bulking and Strength – Wolfson Brands

WOLFSON BRANDS (UK) LIMITED WOLFSON BRANDS (UK) LIMITED Glasgow, May 10, 2025 (GLOBE NEWSWIRE) -- The best legal supplements for…

9 months ago

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes…

9 months ago

Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases

New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following…

9 months ago

Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health

PURCHASE, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.  (NASDAQ: CGTX), a clinical-stage company developing drugs that treat…

9 months ago

Zilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis Ventures

QUEBEC CITY, May 7, 2025 /PRNewswire/ - Zilia Inc. (''Zilia''), a medical technology company pioneering the use of the eye…

9 months ago